These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36058287)

  • 1. Joint effect of blood pressure and glycemic variation on the risk of cardiovascular morbidity and mortality in persons with type 2 diabetes.
    Lin CC; Li CI; Juan YL; Liu CS; Lin CH; Yang SY; Li TC
    Metabolism; 2022 Nov; 136():155308. PubMed ID: 36058287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visit-to-visit glycemic variability is a strong predictor of chronic obstructive pulmonary disease in patients with type 2 diabetes mellitus: Competing risk analysis using a national cohort from the Taiwan diabetes study.
    Chiu HT; Li TC; Li CI; Liu CS; Lin WY; Lin CC
    PLoS One; 2017; 12(5):e0177184. PubMed ID: 28489885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visit-to-Visit Variations in Fasting Plasma Glucose and HbA
    Li TC; Yang CP; Tseng ST; Li CI; Liu CS; Lin WY; Hwang KL; Yang SY; Chiang JH; Lin CC
    Diabetes Care; 2017 Sep; 40(9):1210-1217. PubMed ID: 28705834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of carotid atherosclerosis markers with all-cause and cardiovascular disease-specific mortality in persons with type 2 diabetes: a causal mediation analysis with glucose variation.
    Lin CC; Li CI; Liu CS; Lin CH; Yang SY; Li TC
    Acta Diabetol; 2024 May; 61(5):657-669. PubMed ID: 38393346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Visit-to-Visit Variability of Blood Pressure with Cardiovascular Disease among Type 2 Diabetes Mellitus Patients: A Cohort Study.
    Yu ZB; Li D; Chen XY; Zheng PW; Lin HB; Tang ML; Jin MJ; Wang JB; Chen K
    Diabetes Metab J; 2019 Jun; 43(3):350-367. PubMed ID: 30877712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Visit-to-Visit Variability of Systolic Blood Pressure With Cardiovascular Disease and Mortality in Primary Care Chinese Patients With Type 2 Diabetes-A Retrospective Population-Based Cohort Study.
    Wan EY; Fung CS; Yu EY; Fong DY; Chen JY; Lam CL
    Diabetes Care; 2017 Feb; 40(2):270-279. PubMed ID: 27899498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visit-to-Visit Variability of Fasting Plasma Glucose and the Risk of Cardiovascular Disease and All-Cause Mortality in the General Population.
    Wang A; Liu X; Xu J; Han X; Su Z; Chen S; Zhang N; Wu S; Wang Y; Wang Y
    J Am Heart Assoc; 2017 Nov; 6(12):. PubMed ID: 29187392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of visit-to-visit glycemic variability on the risks of major adverse cardiovascular outcomes and hypoglycemia in patients with different glycemic control and type 2 diabetes.
    Sun B; He F; Gao Y; Zhou J; Sun L; Liu R; Xu H; Chen X; Zhou H; Liu Z; Zhang W
    Endocrine; 2019 Jun; 64(3):536-543. PubMed ID: 30868413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visit-to-visit variability of fasting plasma glucose as predictor of ischemic stroke: competing risk analysis in a national cohort of Taiwan Diabetes Study.
    Lin CC; Yang CP; Li CI; Liu CS; Chen CC; Lin WY; Hwang KL; Yang SY; Li TC
    BMC Med; 2014 Sep; 12():165. PubMed ID: 25255837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Intensive Systolic Blood Pressure Lowering on Cardiovascular Events and Mortality in Patients With Type 2 Diabetes Mellitus on Standard Glycemic Control and in Those Without Diabetes Mellitus: Reconciling Results From ACCORD BP and SPRINT.
    Beddhu S; Chertow GM; Greene T; Whelton PK; Ambrosius WT; Cheung AK; Cutler J; Fine L; Boucher R; Wei G; Zhang C; Kramer H; Bress AP; Kimmel PL; Oparil S; Lewis CE; Rahman M; Cushman WC
    J Am Heart Assoc; 2018 Sep; 7(18):e009326. PubMed ID: 30371182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of visit-to-visit glycemic variability with risk of cardiovascular diseases in high-risk Japanese patients with type 2 diabetes: A subanalysis of the EMPATHY trial.
    Sato M; Inaishi J; Saisho Y; Sato Y; Komuro I; Itoh H
    J Diabetes Investig; 2021 Dec; 12(12):2190-2196. PubMed ID: 34013644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visit-to-Visit Glucose Variability Predicts the Development of End-Stage Renal Disease in Type 2 Diabetes: 10-Year Follow-Up of Taiwan Diabetes Study.
    Yang YF; Li TC; Li CI; Liu CS; Lin WY; Yang SY; Chiang JH; Huang CC; Sung FC; Lin CC
    Medicine (Baltimore); 2015 Nov; 94(44):e1804. PubMed ID: 26554779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visit-to-visit HbA1c variability and systolic blood pressure (SBP) variability are significantly and additively associated with mortality in individuals with type 1 diabetes: An observational study.
    Wightman SS; Sainsbury CAR; Jones GC
    Diabetes Obes Metab; 2018 Apr; 20(4):1014-1017. PubMed ID: 29266630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HbA1c and systolic blood pressure variation to predict all-cause mortality in patients with type 2 diabetes mellitus.
    Lee YC; Chang CT; Chen RH; Wang TY; Chen CC
    Prim Care Diabetes; 2024 Apr; 18(2):146-150. PubMed ID: 38309986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Competing risk analysis on visit-to-visit glucose variations and risk of depression: The Taiwan Diabetes Study.
    Li CI; Liu CS; Lin CH; Lin WY; Lee YD; Yang SY; Li TC; Lin CC
    Diabetes Metab; 2020 Jun; 46(3):223-229. PubMed ID: 31472230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visit-to-visit blood pressure variability in patients with type 2 diabetes with and without previous history of cardiovascular disease.
    Radaelli MG; Ciardullo S; Perra S; Cannistraci R; Bianconi E; Muraca E; Zerbini F; Manzoni G; Grassi G; Mancia G; Lattuada G; Perseghin G
    J Hypertens; 2020 Sep; 38(9):1737-1744. PubMed ID: 32251199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Risk of Cardiovascular Disease Among Type 2 Diabetes Patients According to Average and Visit-to-Visit Variations of HbA1c Levels During the First 3 Years of Diabetes Diagnosis.
    Kim H; Jung DY; Lee SH; Cho JH; Yim HW; Kim HS
    J Korean Med Sci; 2023 Jan; 38(4):e24. PubMed ID: 36718561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visit-to-visit variation of fasting plasma glucose is a predictor of hip fracture in older persons with type 2 diabetes: the Taiwan Diabetes Study.
    Chiang JI; Li TC; Li CI; Liu CS; Meng NH; Lin WY; Yang SY; Chen HJ; Lin CC
    Osteoporos Int; 2016 Dec; 27(12):3587-3597. PubMed ID: 27363401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships between the risk of cardiovascular disease in type 2 diabetes patients and both visit-to-visit variability and time-to-effect differences in blood pressure.
    Takao T; Kimura K; Suka M; Yanagisawa H; Kikuchi M; Kawazu S; Matsuyama Y
    J Diabetes Complications; 2015 Jul; 29(5):699-706. PubMed ID: 25861721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes Mellitus-Related All-Cause and Cardiovascular Mortality in a National Cohort of Adults.
    Raghavan S; Vassy JL; Ho YL; Song RJ; Gagnon DR; Cho K; Wilson PWF; Phillips LS
    J Am Heart Assoc; 2019 Feb; 8(4):e011295. PubMed ID: 30776949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.